News Lenz Therapeutics’ Eye Disease Drugs Meet Main Goal Of Late-stage Study by Medscape • 2024/04/03 • 0 Comments Lenz Therapeutics said on Wednesday its experimental drugs to treat loss of near vision met the main goal of a late-stage study, sending its shares up nearly 23% before the... Reuters Health Information Full Story →